We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+16.25%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$183M
AUM Growth
+$8.09M
Cap. Flow
+$22.6M
Cap. Flow %
12.29%
Top 10 Hldgs %
98.91%
Holding
12
New
1
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
STIM icon
Neuronetics
STIM
+$22.4M
2
PULM icon
Pulmatrix
PULM
+$388K

Top Sells

Rank Stock Value
1
TTOO
T2 Biosystems, Inc
TTOO
+$266K

Sector Composition

Rank Sector Weight
1 Healthcare 60.97%
2 Communication Services 31.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDLX icon
1
Cardlytics
CDLX
$22.2M
$57.4M 31.26%
263,626
– –
FATE icon
2
Fate Therapeutics
FATE
$275M
$28M 15.28%
2,473,186
– –
KALA icon
3
KALA BIO
KALA
$12.5M
$25.5M 13.9%
744
– –
STIM icon
4
Neuronetics
STIM
$127M
$21.9M 11.96%
+824,765
New +$22.4M
RNAC icon
5
Cartesian Therapeutics
RNAC
$218M
$21.3M 11.6%
53,560
– –
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
$14.3M 7.77%
368
-7
-2% -$266K
XFOR icon
7
X4 Pharmaceuticals
XFOR
$377M
$6.78M 3.7%
10,383
– –
TRVN
8
DELISTED
Trevena, Inc.
TRVN
$2.96M 1.61%
3,286
– –
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.69M 0.92%
246,076
– –
ATYR
10
aTyr Pharma
ATYR
$47.4M
$1.66M 0.91%
130,571
– –
PULM icon
11
Pulmatrix
PULM
$6.1M
$1.62M 0.88%
17,972
+3,990
+29% +$388K
DARE icon
12
Dare Bioscience
DARE
$17.4M
$382K 0.21%
27,187
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q2 2018 Portfolio in Review

As of Q2 2018, Polaris Venture Management Co V held 12 positions worth $183M, up 4.6% from $175M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Polaris Venture Management Co V deployed $22.6M of net new capital in Q2 2018, opening 1 new position and adding to 1 existing holding. Its largest new stake was Neuronetics: 824,765 shares worth $21.9M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 71% a quarter earlier, followed by Communication Services.

On the sell side, the largest reduction was T2 Biosystems, Inc, an estimated $266K trimmed.

  • Polaris Venture Management Co V's largest Q2 2018 buy was Neuronetics: 824,765 shares worth $21.9M.
  • Polaris Venture Management Co V added most to Pulmatrix in Q2 2018, an estimated $388K increase.
  • Polaris Venture Management Co V's biggest Q2 2018 reduction was T2 Biosystems, Inc, cutting an estimated $266K.
  • Polaris Venture Management Co V's ten largest holdings make up 99% of its $183M portfolio in Q2 2018.
  • Polaris Venture Management Co V opened 1 new position and closed 0 in Q2 2018.
  • Polaris Venture Management Co V's portfolio value rose 4.6% quarter-over-quarter to $183M.

Based on Polaris Venture Management Co V's 13F filing for Q2 2018, filed 14 Aug 2018.